Fig. 1

GC patient tumors exhibit HOXA-AS3 upregulation that is correlated with poor patient prognosis. a The upregulation of HOXA-AS3 in GC tumor tissues was observed in the TCGA database. b Relative HOXA-AS3 levels were measured via qPCR in 82 pairs of GC tumor tissues and paired control samples. c, d GC patients with high and low levels of HOXA-AS3 expression (n = 41 each) were compared to assess their relative OS and DFS